Getwell Pharmaceuticals — Cyclophosphamide Exporter Profile
Indian Pharmaceutical Exporter · #6 for Cyclophosphamide · $241.8K export value · DGFT Verified
Getwell Pharmaceuticals is the #6 Indian exporter of Cyclophosphamide with $241.8K in export value and 94 verified shipments. Getwell Pharmaceuticals holds a 1.2% market share in Cyclophosphamide exports across 9 countries. The company exports 7 pharmaceutical products worth $1.5M across 3 therapeutic categories.
Getwell Pharmaceuticals — Cyclophosphamide Export Profile: Buyers & Destinations
Where Does Getwell Pharmaceuticals Export Cyclophosphamide?
| Country | Value | Shipments | Share |
|---|---|---|---|
| PHILIPPINES | $216.3K | 45 | 89.4% |
| NEPAL | $8.3K | 13 | 3.4% |
| JAMAICA | $5.5K | 12 | 2.3% |
| MADAGASCAR | $4.7K | 4 | 1.9% |
| KENYA | $3.7K | 14 | 1.5% |
| KOREA,REPUBLIC OF | $2.0K | 1 | 0.8% |
| NICARAGUA | $1.3K | 1 | 0.5% |
| MAURITIUS | $62 | 3 | 0.0% |
| MONGOLIA | $0 | 1 | 0.0% |
Getwell Pharmaceuticals exports Cyclophosphamide to 9 countries. The largest destination is PHILIPPINES accounting for 89.4% of Getwell Pharmaceuticals's Cyclophosphamide shipments, followed by NEPAL (3.4%) and JAMAICA (2.3%). These destinations reflect Getwell Pharmaceuticals's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Cyclophosphamide from Getwell Pharmaceuticals?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AMBICA INTERNATIONAL CORPORATION | PHILIPPINES | $208.0K | 44 |
| AMBICA INTERNATIONAL CORPORATI | PHILIPPINES | $8.3K | 1 |
| RECHARGED DISTRIBUTORS LIMITED | JAMAICA | $5.5K | 12 |
| VISION CARE INTERNATIONAL PVT. LTD. | NEPAL | $5.5K | 9 |
| CENTRALE D'ACHATS DE MEDICAMENTS | MADAGASCAR | $4.7K | 3 |
| VISION CARE INTERNATIONAL PVT LTD | NEPAL | $2.2K | 3 |
| TSOMBO LLC | MONGOLIA | $2.0K | 2 |
| M/S NAIROBI ENTERPRISES LTD. | KENYA | $1.7K | 5 |
| NORVICH HEALTH S.A | NICARAGUA | $1.3K | 1 |
| M/S NAIROBI ENTERPRISES LTD. | KENYA | $1.1K | 3 |
Getwell Pharmaceuticals supplies Cyclophosphamide to 15 buyers globally. The largest buyer is AMBICA INTERNATIONAL CORPORATION (PHILIPPINES), followed by AMBICA INTERNATIONAL CORPORATI (PHILIPPINES) and RECHARGED DISTRIBUTORS LIMITED (JAMAICA). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Cyclophosphamide Export Value and How Much Does Getwell Pharmaceuticals Contribute?
India exported $4.6M worth of Cyclophosphamide through 2,113 shipments from 259 suppliers to 114 countries, serving 518 buyers globally. Getwell Pharmaceuticals contributes $241.8K to this total, accounting for 1.2% of India's Cyclophosphamide exports. Getwell Pharmaceuticals ships Cyclophosphamide to 9 countries through 15 buyers.
What Is the Average Shipment Value for Getwell Pharmaceuticals's Cyclophosphamide Exports?
Getwell Pharmaceuticals's average Cyclophosphamide shipment value is $2.6K per consignment, based on 94 shipments totaling $241.8K. The largest destination is PHILIPPINES (89.4% of Getwell Pharmaceuticals's Cyclophosphamide exports).
How Does Getwell Pharmaceuticals Compare to Other Indian Cyclophosphamide Exporters?
Getwell Pharmaceuticals ranks #6 among 259 Indian Cyclophosphamide exporters with a 1.2% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($1.1M), ALEMBIC PHARMACEUTICALS LIMITED ($850.4K), CIPLA LIMITED ($550.0K). Getwell Pharmaceuticals processed 94 shipments to 9 destination countries.
What Cyclophosphamide Formulations Does Getwell Pharmaceuticals Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| CYTOACE- 500 MG CYCLOPHOSPHAMIDE FOR IN | $19.3K | 4 |
| GLOTOXAN 500MG (CYCLOPHOSPHAMIDE FOR INJ | $10.0K | 2 |
| GLOTOXAN-500MG (CYCLOPHOSPHAMIDE FOR INJ | $9.9K | 2 |
| GLOTOXAN-500MG CYCLOPHOSPHAMIDE FOR INJ | $9.7K | 2 |
| CYCLIXINE- 500 MG (CYCLOPHOSPHAMIDE FOR | $9.7K | 2 |
| GLOTOXAN 500MG CYCLOPHOSPHAMIDE FOR INJECTION USP BATCH NO 3GCY03 MFG DT 01 2023 EXP DT 12 2024 | $8.9K | 1 |
| CYTOACE- 1 G CYCLOPHOSPHAMIDE FOR INJEC | $8.7K | 1 |
| GLOTOXAN-500MG (CYCLOPHOSPHAMIDE FOR INJECTION USP)BATCH NO. 4GCY04, MFG.DT. 02/2024, EXP.DT. 01/2026 | $8.4K | 1 |
| CYTOACE 1G (CYCLOPHOSPHAMIDE FOR INJECTI | $8.4K | 1 |
| CYTOACE- 1 G CYCLOPHOSPHAMIDE FOR INJECTION USPBATCH NO. 3GCY42 MANUFACTURING .DT. 10/2023 EXP.DT. 09/2025 | $8.3K | 1 |
Getwell Pharmaceuticals exports 56 distinct Cyclophosphamide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is CYTOACE- 500 MG CYCLOPHOSPHAMIDE FOR IN with 4 shipments worth $19.3K.
How Does Getwell Pharmaceuticals Compare to Nearest Cyclophosphamide Exporters?
Exporters ranked immediately above and below #6 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 4 | VENUS REMEDIES LIMITED | $492.4K | 13 | 5 | $37.9K |
| 5 | SP ACCURE LABS PRIVATE LIMITED | $272.7K | 22 | 5 | $12.4K |
| 6 | GETWELL PHARMACEUTICALS ★ | $241.8K | 94 | 9 | $2.6K |
| 7 | KWALITY PHARMACEUTICALS LIMITED | $235.6K | 19 | 4 | $12.4K |
| 8 | VAMA LIFECARE PRIVATE LIMITED | $204.4K | 21 | 6 | $9.7K |
Getwell Pharmaceuticals ranks #6 among 259 Indian Cyclophosphamide exporters. Average shipment value of $2.6K compared to the market average of $17.9K. The closest competitors by value are VENUS REMEDIES LIMITED and SP ACCURE LABS PRIVATE LIMITED.
Which Indian Ports Ship Cyclophosphamide Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 561 | 26.5% |
| SAHAR AIR CARGO ACC (INBOM4) | 442 | 20.9% |
| DELHI AIR | 246 | 11.6% |
| DELHI AIR CARGO ACC (INDEL4) | 189 | 8.9% |
| Bombay Air | 154 | 7.3% |
| Delhi Air | 51 | 2.4% |
| Bombay Air Cargo | 51 | 2.4% |
| HYDERABAD AIR | 36 | 1.7% |
What Other Oncology Products Does Getwell Pharmaceuticals Export?
Getwell Pharmaceuticals also exports these oncology products. Each links to the detailed product page.
About Getwell Pharmaceuticals
Getwell Pharmaceuticals exports 7 products worth $1.5M. Beyond Cyclophosphamide, top products include Protein, Doxorubicin, Ifosfamide, Etoposide, Fluorouracil. View the complete Getwell Pharmaceuticals profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Cyclophosphamide — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Cyclophosphamide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Getwell Pharmaceuticals matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 94 individual customs records matching Getwell Pharmaceuticals exporting Cyclophosphamide, covering 56 formulations to 9 countries via 15 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 114+ countries, 518+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Cyclophosphamide Export Data from Getwell Pharmaceuticals
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Getwell Pharmaceuticals's Cyclophosphamide exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Getwell Pharmaceuticals
Full Company Profile →
7 products · $1.5M total trade · 3 categories
Cyclophosphamide Stats
Company Overview
Top Products by Getwell Pharmaceuticals
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Getwell Pharmaceuticals.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Cyclophosphamide. For current shipment-level data, contact TransData Nexus.